[HTML][HTML] Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism
GJAM Boon, N Rein, HJ Bogaard, YM Ende-Verhaar… - PloS one, 2020 - journals.plos.org
Background The pathophysiology of chronic thromboembolic pulmonary hypertension
(CTEPH) is not fully understood. Poor-quality anticoagulation may contribute to a higher risk
of CTEPH after acute pulmonary embolism (PE), partly explaining the transition from acute
PE to CTEPH. We assessed the association between the time in therapeutic range (TTR) of
vitamin-K antagonist (VKA) treatment and incidence of CTEPH after a PE diagnosis.
Methods Case-control study in which the time spent in, under and above therapeutic range …
(CTEPH) is not fully understood. Poor-quality anticoagulation may contribute to a higher risk
of CTEPH after acute pulmonary embolism (PE), partly explaining the transition from acute
PE to CTEPH. We assessed the association between the time in therapeutic range (TTR) of
vitamin-K antagonist (VKA) treatment and incidence of CTEPH after a PE diagnosis.
Methods Case-control study in which the time spent in, under and above therapeutic range …
Correction: Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism
GJAM Boon, N van Rein, HJ Bogaard… - Plos one, 2020 - journals.plos.org
The second author's initials also appear incorrectly in the citation. The correct citation is:
Boon GJAM, van Rein N, Bogaard HJ, Ende-Verhaar YM, Huisman MV, Kroft LJM, et
al.(2020) Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary
embolism. PLoS ONE 15 (4): e0232354. https://doi. org/10.1371/journal. pone. 0232354.
Boon GJAM, van Rein N, Bogaard HJ, Ende-Verhaar YM, Huisman MV, Kroft LJM, et
al.(2020) Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary
embolism. PLoS ONE 15 (4): e0232354. https://doi. org/10.1371/journal. pone. 0232354.
以上显示的是最相近的搜索结果。 查看全部搜索结果